Utility of telemedicine in the treatment of patients with chronic HCV infection using DAAs in remote areas with limited resources
Liver Int
.
2021 Aug;41(8):1979-1980.
doi: 10.1111/liv.14982.
Epub 2021 Jul 4.
Authors
Mohamed Abd Allah
1
,
Sherif Wahed
2
,
Islam Ammar
3
,
Ehab Kamal
1
,
Mohamed Alboraie
4
,
Wael Abdel-Razek
5
,
Mohamed Hassany
6
,
Magdy El-Serafy
7
,
Imam Waked
5
,
Wahid Doss
7
Affiliations
1
Medical Research Division, National Research Center, Giza, Egypt.
2
Al-Wahat Al-Bahariya Central Hospital, Giza, Egypt.
3
Department of Gastroenterology, Hepatology and Infectious Diseases, Al-Azhar University, Cairo, Egypt.
4
Department of Internal Medicine, Al-Azhar University, Cairo, Egypt.
5
National Liver Institute, Menoufia University, Shebin Elkom, Egypt.
6
National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.
7
Endemic Medicine and Hepatology Department, Cairo University, Cairo, Egypt.
PMID:
34153175
DOI:
10.1111/liv.14982
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use
Hepacivirus
Hepatitis C* / drug therapy
Humans
Telemedicine*
Substances
Antiviral Agents